• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法布瑞氏病患者的心肌纵向应变、心肌贮备和心肌肥厚。

Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.

机构信息

Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK.

Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.

出版信息

Heart. 2019 Mar;105(6):470-476. doi: 10.1136/heartjnl-2018-313699. Epub 2018 Oct 3.

DOI:10.1136/heartjnl-2018-313699
PMID:30282640
Abstract

INTRODUCTION

Detecting early cardiac involvement in Fabry disease (FD) is important because therapy may alter disease progression. Cardiovascular magnetic resonance (CMR) can detect T1 lowering, representing myocardial sphingolipid storage. In many diseases, early mechanical dysfunction may be detected by abnormal global longitudinal strain (GLS). We explored the relationship of early mechanical dysfunction and sphingolipid deposition in FD.

METHODS

An observational study of 221 FD and 77 healthy volunteers (HVs) who underwent CMR (LV volumes, mass, native T1, GLS, late gadolinium enhancement), ECG and blood biomarkers, as part of the prospective multicentre Fabry400 study.

RESULTS

All FD had normal LV ejection fraction (EF 73%±8%). Mean indexed LV mass (LVMi) was 89±39 g/m in FD and 55.6±10 g/m in HV. 102 (46%) FD participants had left ventricular hypertrophy (LVH). There was a negative correlation between GLS and native T1 in FD patients (r=-0.515, p<0.001). In FD patients without LVH (early disease), as native T1 reduced there was impairment in GLS (r=-0.285, p<0.002). In the total FD cohort, ECG abnormalities were associated with a significant impairment in GLS compared with those without ECG abnormalities (abnormal: -16.7±3.5 vs normal: -20.2±2.4, p<0.001).

CONCLUSIONS

GLS in FD correlates with an increase in LVMi, storage and the presence of ECG abnormalities. In LVH-negative FD (early disease), impairment in GLS is associated with a reduction in native T1, suggesting that mechanical dysfunction occurs before evidence of sphingolipid deposition (low T1).

TRIAL REGISTRATION NUMBER

NCT03199001; Results.

摘要

简介

在法布里病(FD)中早期检测心脏受累非常重要,因为治疗可能会改变疾病的进程。心血管磁共振(CMR)可以检测到 T1 降低,代表心肌鞘脂储存。在许多疾病中,早期机械功能障碍可能通过异常的整体纵向应变(GLS)来检测。我们探讨了 FD 中早期机械功能障碍和鞘脂沉积之间的关系。

方法

这是一项前瞻性多中心 Fabry400 研究的观察性研究,共纳入 221 例 FD 患者和 77 名健康志愿者(HV),他们接受了 CMR(LV 容积、质量、心肌 T1 值、GLS、晚期钆增强)、心电图和血液生物标志物检查。

结果

所有 FD 患者的左心室射血分数(EF 73%±8%)均正常。FD 患者的平均左心室质量指数(LVMi)为 89±39 g/m,HV 为 55.6±10 g/m。102 例(46%)FD 患者存在左心室肥厚(LVH)。FD 患者的 GLS 与 native T1 呈负相关(r=-0.515,p<0.001)。在无 LVH(早期疾病)的 FD 患者中,随着 native T1 的降低,GLS 受损(r=-0.285,p<0.002)。在 FD 患者中,与心电图正常者相比,心电图异常患者的 GLS 显著受损(异常:-16.7±3.5 vs 正常:-20.2±2.4,p<0.001)。

结论

FD 患者的 GLS 与 LVMi 的增加、储存以及心电图异常有关。在 LVH 阴性 FD(早期疾病)中,GLS 受损与 native T1 的降低有关,提示在出现鞘脂沉积(低 T1)之前就已经出现了机械功能障碍。

试验注册号

NCT03199001;结果。

相似文献

1
Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.法布瑞氏病患者的心肌纵向应变、心肌贮备和心肌肥厚。
Heart. 2019 Mar;105(6):470-476. doi: 10.1136/heartjnl-2018-313699. Epub 2018 Oct 3.
2
Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.通过心血管磁共振评估法布里病的基底-顶点周向应变梯度缺失:与 T1 映射、晚期钆增强和心肌肥厚的关系。
J Cardiovasc Magn Reson. 2019 Aug 1;21(1):45. doi: 10.1186/s12968-019-0557-0.
3
Proposed Stages of Myocardial Phenotype Development in Fabry Disease.法布里病心肌表型发育的拟议阶段。
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1673-1683. doi: 10.1016/j.jcmg.2018.03.020. Epub 2018 May 16.
4
The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.法布瑞氏病心肌表型的肥大前期和可检测存储前期。
Eur Heart J Cardiovasc Imaging. 2021 Jun 22;22(7):790-799. doi: 10.1093/ehjci/jeaa101.
5
Cardiac Phenotype of Prehypertrophic Fabry Disease.肥厚型 Fabry 病的心脏表型。
Circ Cardiovasc Imaging. 2018 Jun;11(6):e007168. doi: 10.1161/CIRCIMAGING.117.007168.
6
Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease.法布瑞氏病中心肌水肿、心肌细胞损伤与疾病严重程度。
Circ Cardiovasc Imaging. 2020 Mar;13(3):e010171. doi: 10.1161/CIRCIMAGING.119.010171. Epub 2020 Mar 2.
7
Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance.天然心肌T1映射在法布里病评估中的可重复性及其在心血管磁共振早期检测心脏受累中的作用。
J Cardiovasc Magn Reson. 2014 Dec 5;16(1):99. doi: 10.1186/s12968-014-0099-4.
8
Quantification of myocardial deformation in patients with Fabry disease by cardiovascular magnetic resonance feature tracking imaging.通过心血管磁共振特征追踪成像对法布里病患者的心肌变形进行定量分析。
Cardiovasc Diagn Ther. 2021 Feb;11(1):91-101. doi: 10.21037/cdt-20-897.
9
Three-dimensional speckle tracking longitudinal strain is related to myocardial fibrosis determined by late-gadolinium enhancement.三维斑点追踪纵向应变与延迟钆增强测定的心肌纤维化相关。
Int J Cardiovasc Imaging. 2017 Sep;33(9):1351-1360. doi: 10.1007/s10554-017-1115-1. Epub 2017 Mar 15.
10
Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy.酶替代治疗 1 年后法布病患者心肌储存、炎症和心脏表型。
Circ Cardiovasc Imaging. 2019 Dec;12(12):e009430. doi: 10.1161/CIRCIMAGING.119.009430. Epub 2019 Dec 12.

引用本文的文献

1
Cardiac Magnetic Resonance in the Evaluation and Management of Nonischemic Cardiomyopathies.心脏磁共振成像在非缺血性心肌病评估与管理中的应用
JACC Heart Fail. 2025 Sep;13(9):102525. doi: 10.1016/j.jchf.2025.102525. Epub 2025 Jul 5.
2
Cardiac Magnetic Resonance in Heart Failure: Diagnostic and Prognostic Assessments.心力衰竭中的心脏磁共振成像:诊断与预后评估
J Cardiovasc Dev Dis. 2025 May 23;12(6):200. doi: 10.3390/jcdd12060200.
3
Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets.
心血管疾病中的神经酰胺:作为独立风险预测因子和新型治疗靶点的新作用。
Cardiovasc Res. 2025 Aug 14;121(9):1345-1358. doi: 10.1093/cvr/cvaf093.
4
Subclinical Cardiac Involvement in Asymptomatic ATTR Mutation Carriers: Insights from Cardiac MRI, Myocardial Strain, and Mapping Techniques.无症状转甲状腺素蛋白淀粉样变突变携带者的亚临床心脏受累:来自心脏磁共振成像、心肌应变和标测技术的见解
J Cardiovasc Dev Dis. 2025 May 1;12(5):172. doi: 10.3390/jcdd12050172.
5
Fabry Disease: Insights into Pathophysiology and Novel Therapeutic Strategies.法布里病:对病理生理学和新型治疗策略的见解
Biomedicines. 2025 Mar 4;13(3):624. doi: 10.3390/biomedicines13030624.
6
Changes in peak oxygen consumption in Fabry disease and associations with cardiomyopathy severity.法布里病患者峰值耗氧量的变化及其与心肌病严重程度的关联。
Heart. 2025 Feb 12;111(5):230-238. doi: 10.1136/heartjnl-2024-324553.
7
Screening for Fabry disease in patients with hypertrophic cardiomyopathy using cardiac magnetic resonance imaging.使用心脏磁共振成像对肥厚型心肌病患者进行法布里病筛查。
Eur Radiol. 2025 May;35(5):2888-2898. doi: 10.1007/s00330-024-11203-7. Epub 2024 Nov 19.
8
Myocardial fibrosis in the posterior myocardium in Fabry disease is associated with global rather than regional longitudinal strain reduction.法布里病患者后心肌的心肌纤维化与整体纵向应变降低有关,而非局部纵向应变降低。
Eur Heart J Cardiovasc Imaging. 2025 Jan 31;26(2):368-370. doi: 10.1093/ehjci/jeae279.
9
Cardiac involvement in Anderson-Fabry disease. The role of advanced echocardiography.心脏受累在安德森-法布里病中的情况。先进超声心动图的作用。
Front Cardiovasc Med. 2024 Sep 2;11:1440636. doi: 10.3389/fcvm.2024.1440636. eCollection 2024.
10
Contemporary Multimodality Imaging for Diagnosis and Management of Fabry Cardiomyopathy.用于法布里心肌病诊断和管理的当代多模态成像
J Clin Med. 2024 Aug 14;13(16):4771. doi: 10.3390/jcm13164771.